Taipei County, Taiwan

Ching-Len Liao

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ching-Len Liao in Recombinant Viral Constructs

Introduction

Ching-Len Liao is an accomplished inventor based in Taipei County, Taiwan. He has made significant contributions to the field of virology, particularly through his innovative work on recombinant viral constructs. His research focuses on the development of viral constructs that can express exogenous polypeptides, which have important applications in immunization.

Latest Patents

Ching-Len Liao holds a patent for "Recombinant flaviviral constructs and uses thereof." This patent describes a recombinant viral construct derived from the Japanese encephalitis virus (JEV). The construct is designed to express an exogenous polypeptide within a cell, encoding a fusion protein that includes both the exogenous polypeptide and a segment of the JEV non-structural protein 1 (JEV NS1). Notably, the production of this recombinant fusion protein does not interfere with viral replication. The JEV particles produced from this construct are capable of eliciting an immune response, providing protective immunization against the exogenous polypeptide.

Career Highlights

Ching-Len Liao is affiliated with the National Defensive Medical Center, where he continues to advance his research in viral constructs. His work has the potential to impact vaccine development and therapeutic strategies against viral infections.

Collaborations

Ching-Len collaborates with Jia-Teh Liao, who is also involved in research related to viral constructs. Their partnership enhances the scope and depth of their innovative projects.

Conclusion

Ching-Len Liao's contributions to the field of virology through his patented recombinant viral constructs demonstrate his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for future applications in immunization and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…